Medical Toxicology of Drug Abuse: Synthesized Chemicals and Psychoactive Plants By Donald G. Barceloux(auth.)
2012 | 1068 Pages | ISBN: 0471727601 | PDF | 18 MB
2012 | 1068 Pages | ISBN: 0471727601 | PDF | 18 MB
This book provides a broad reference covering important drugs of abuse including amphetamines, opiates, and steroids. It also covers psychoactive plants such as caffeine, peyote, and psilocybin. It provides chemical structures, analytical methods, clinical features, and treatments of these drugs of abuse, serving as a highly useful, in-depth supplement to a general medical toxicology book. The style allows for the easy application of the contents to searchable databases and other electronic products, making this an essential resource for practitioners in medical toxicology, industrial hygiene, occupational medicine, pharmaceuticals, environmental organizations, pathology, and related fields.Content: Chapter 1 Amphetamine and Methamphetamine (pages 1–56): Chapter 2 Methylphenidate (pages 57–68): Chapter 3 Prolintane (pages 69–71): Chapter 4 Propylhexedrine (pages 72–76): Chapter 5 Flunitrazepam (pages 77–88): Chapter 6 Gamma Hydroxybutyrate and Related Drugs (pages 89–109): Chapter 7 Ketamine (pages 110–119): Chapter 8 Methcathinone, Mephedrone, and Methylone (pages 120–125): Chapter 9 Methylenedioxymethamphetamine (Ecstasy, MDMA) (pages 126–155): Nicholas A. BuckleyChapter 10 Psychoactive Phenethylamine, Piperazine, and Pyrrolidinophenone Derivatives (pages 156–192): Brandon Wills and Timothy EricksonChapter 11 Tryptamine Designer Drugs (pages 193–199): Chapter 12 Diuretics, Ipecac, and Laxatives (pages 200–232): Cyrus RanganChapter 13 Noradrenergic Agents (pages 233–254): Cyrus RanganChapter 14 Serotoninergic and Mixed Agents (pages 255–274): Chapter 15 Anabolic?Androgenic Steroids (pages 275–294): Chapter 16 Clenbuterol and Salbutamol (Albuterol) (pages 295–305): James Rhee and Timothy EricksonChapter 17 Erythropoietin Stimulation and Other Blood Doping Methods (pages 306–325): James Rhee and Timothy EricksonChapter 18 Human Chorionic Gonadotropin (pages 326–333): Chapter 19 Human Growth Hormone and Insulin?Like Growth Factor (pages 334–350): Chapter 20 Nutritional Supplements (pages 351–364): Chapter 21 Ethanol (pages 365–451): Chapter 22 Lysergic Acid Diethylamide (LSD) (pages 452–466): Chapter 23 Barbiturates: (Amobarbital, Butalbital, Pentobarbital, Secobarbital) (pages 467–485): Chapter 24 Ethchlorvynol (pages 486–490): Chapter 25 Glutethimide (pages 491–496): Chapter 26 Meprobamate (pages 497–503): Chapter 27 Methaqualone and Related Compounds (pages 504–513): Chapter 28 Buprenorphine (pages 514–526): Chapter 29 Dextromethorphan (pages 527–538): Chapter 30 Fentanyl Analogues (pages 539–545): Chapter 31 Heroin and the Opium Poppy Plant (Papaver somniferum L.) (pages 546–578): Chapter 32 Methadone (pages 579–602): Chapter 33 1?Methyl?4?phenyl?1,2,5,6?Tetrahydropyridine (MPTP) (pages 603–607): Chapter 34 Phencyclidine and Phencyclidine Analogues (pages 608–632): Chapter 35 Volatile Substance Abuse (pages 633–641): Chapter 36 Chloroform (pages 642–646): Chapter 37 Ethers (pages 647–652): Chapter 38 Halogenated Ethers (Enflurane, Isoflurane, Methoxyflurane, Sevoflurane) (pages 653–663): Chapter 39 Halothane (pages 664–669): Chapter 40 Nitrous Oxide (pages 670–675): Chapter 41 Fluorinated Alkanes (pages 676–683): Chapter 42 Butane, Isobutane, and Propane (pages 684–690): Chapter 43 Ethyl Chloride (pages 691–694): Chapter 44 Gasoline (pages 695–701): Chapter 45 n?Hexane (pages 702–708): Chapter 46 Methanol (pages 709–715): Chapter 47 Naphthalene and para?Dichlorobenzene (Mothballs) (pages 716–724): Chapter 48 Toluene (pages 725–736): Chapter 49 Trichloroethane (pages 737–742): Chapter 50 Trichloroethylene (pages 743–750): Chapter 51 Amyl and Butyl Nitrites (pages 751–757): Chapter 52 Absinthe (pages 759–767): Chapter 53 Ayahuasca, Harmala Alkaloids, and Dimethyltryptamines (pages 768–780): Chapter 54 Betel Quid and Areca Nut (pages 781–787): Chapter 55 Caffeine (pages 788–804): Chapter 56 Cocaine (pages 805–866): Chapter 57 Ibogaine (Tabernanthe iboga Baill.) (pages 867–872): Chapter 58 Khat (Catha edulis (Vahl) Forsskal ex Endl.) and Cathinone (pages 873–879): Chapter 59 Kratom [Mitragyna speciosa (Korth.) Havil.] (pages 880–885): Chapter 60 Marijuana (Cannabis sativa L.) and Synthetic Cannabinoids (pages 886–931): Chapter 61 Mate Tea (Ilex paraguariensis A. St. Hil.) (pages 932–937): Chapter 62 Morning Glory Family (Convolvulaceae) (pages 938–943): Chapter 63 Peyote [Lophophora williamsii (Lem. Ex Salm?Dyck) Coult.] and Mescaline (pages 944–949): Chapter 64 Psilocybin and Hallucinogenic Mushrooms (pages 950–960): Chapter 65 Salvia divinorum Epling & Jativa and Salvinorin A (pages 961–967): Chapter 66 Tobacco, Nicotine, and Pituri (pages 968–992):